We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YEXT icon
1701
Yext
YEXT
$593M
$207K ﹤0.01%
20,900
– –
ATRI
1702
DELISTED
Atrion Corp
ATRI
$207K ﹤0.01%
293
– –
JRVR icon
1703
James River Group Holdings
JRVR
$205M
$206K ﹤0.01%
7,137
– –
RMAX icon
1704
RE/MAX Holdings
RMAX
$268M
$206K ﹤0.01%
6,765
– –
VVNT
1705
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$206K ﹤0.01%
21,100
– –
SENS icon
1706
Senseonics Holdings Inc
SENS
$426M
$205K ﹤0.01%
+3,845
New +$250K
AMRX icon
1707
Amneal Pharmaceuticals
AMRX
$6.18B
$202K ﹤0.01%
42,274
– –
ACRS icon
1708
Aclaris Therapeutics
ACRS
$866M
$201K ﹤0.01%
+13,800
New +$209K
PPC icon
1709
Pilgrim's Pride
PPC
$6.49B
$200K ﹤0.01%
7,100
-11,200
-61% -$319K
HTLD icon
1710
Heartland Express
HTLD
$977M
$199K ﹤0.01%
11,816
– –
WW
1711
DELISTED
WW International
WW
$194K ﹤0.01%
12,058
– –
PGEN icon
1712
Precigen
PGEN
$2.42B
$191K ﹤0.01%
51,504
+37,900
+279% +$163K
ALLO icon
1713
Allogene Therapeutics
ALLO
$725M
$189K ﹤0.01%
12,700
– –
WKHS icon
1714
Workhorse Group
WKHS
$33.3M
$189K ﹤0.01%
14
+8
+133% +$145K
TVRD
1715
Tvardi Therapeutics
TVRD
$22.5M
$189K ﹤0.01%
431
– –
AMWL icon
1716
American Well
AMWL
$224M
$188K ﹤0.01%
1,560
– –
ZYME icon
1717
Zymeworks
ZYME
$1.78B
$188K ﹤0.01%
11,500
– –
INO icon
1718
Inovio Pharmaceuticals
INO
$94.9M
$185K ﹤0.01%
3,083
– –
JMIA
1719
Jumia Technologies
JMIA
$784M
$185K ﹤0.01%
16,200
+1,500
+10% +$23.4K
NNOX icon
1720
Nano X Imaging
NNOX
$74.3M
$182K ﹤0.01%
12,500
-3,600
-22% -$74.6K
GRWG icon
1721
GrowGeneration
GRWG
$108M
$180K ﹤0.01%
+13,800
New +$264K
KLRS
1722
Kalaris Therapeutics
KLRS
$93.6M
$173K ﹤0.01%
583
– –
DCH
1723
Dauch Corp
DCH
$1.59B
$167K ﹤0.01%
17,946
– –
IBRX icon
1724
ImmunityBio
IBRX
$8.22B
$164K ﹤0.01%
26,900
+10,900
+68% +$81.9K
PRPL icon
1725
Purple Innovation
PRPL
$29.4M
$163K ﹤0.01%
492
– –
67 68
69
70 71

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.